TARSUS PHARMACEUTICALS, INC. (TARS)
Clinical trial NCT07428408 updates: 1. start date: 2026-02-25 → 2026-08-25 2. completion date: 2026-09-01 → 2026-11-01 3. primary completion date: 2026-07-01 → 2026-09-10
Clinical trial NCT07428408 updates: 1. start date: 2026-02-25 → 2026-08-25 2. completion date: 2026-09-01 → 2026-11-01 3. primary completion date: 2026-07-01 → 2026-09-10
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical